Director of Research and Development

Retham Technologies

Curtis Jones received his Bachelor of Science in Chemistry from the University of Wisconsin-Milwaukee in 2012. He has been involved in research focused on the diagnosis, treatment, and pathophysiology of heparin-induced thrombocytopenia, an adverse reaction to heparin treatment, from 2012-2019 while at the BloodCenter of Wisconsin. In 2019, Curtis joined Retham Technologies, a Wisconsin-based startup founded by Drs. Anand Padmanabhan and Daniel Sem, which is focused on developing improved diagnostic assays for heparin-induced thrombocytopenia where he currently serves as Director of Research and Development.